Literature DB >> 11012603

Disaccharide analysis of skin glycosaminoglycans in atrophoderma of Pasini and Pierini.

Y Yokoyama1, S Akimoto, O Ishikawa.   

Abstract

There are divergent opinions as to whether atrophoderma of Pasini and Pierini (APP) is a nosologic entity or a primary atrophic morphoea. In this study, we used high performance liquid chromatography to analyse the skin disaccharide contents of glycosaminoglycan (GAG) in two patients with APP and compared the results with those from a typical atrophic morphoea patient. Perilesional uninvolved skin was used as a control in each patient. In the atrophic phase morphoea, both the total amount of disaccharide per skin punch-biopsy and the amount of DeltaDi-4S(DS) - the main disaccharide unit of dermatan sulphate - per mg dry weight were increased. These changes were consistent with sclerotic phase morphoea. In contrast, the total amount of disaccharide per skin punch-biopsy was decreased and the amount of DeltaDi-4S(DS) per mg dry weight was decreased or unchanged in APP. Our results suggest that GAG metabolism in APP may be unique and quite different from that in morphoea.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012603     DOI: 10.1046/j.1365-2230.2000.00682.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  Congenital atrophoderma of Pasini and Pierini.

Authors:  Sung Kwon Kim; Seung Ho Rhee; You Chan Kim; Eun So Lee; Hee Young Kang
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

2.  Linear atrophoderma of Moulin.

Authors:  Siew-Kiang Tan; Yong-Kwang Tay
Journal:  JAAD Case Rep       Date:  2016-01-08

3.  Idiopathic Atrophoderma of Pasini and Pierini: Case report and literature review.

Authors:  Anastasiya Muntyanu; Margaret Redpath; Osama Roshdy; Abdulhadi Jfri
Journal:  Clin Case Rep       Date:  2018-12-18

4.  Atrophoderma of pasini and pierini.

Authors:  Anubhav Garg; Pramod Kumar
Journal:  Indian Dermatol Online J       Date:  2011-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.